uniQure N.V. Files 8-K for Material Definitive Agreement
Ticker: QURE · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1590560
| Field | Detail |
|---|---|
| Company | Uniqure N.V. (QURE) |
| Form Type | 8-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $47.50, $0.0001, $323.75 million, $300 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-event
TL;DR
uniQure signed a big deal, filing an 8-K on 9/25/25.
AI Summary
On September 25, 2025, uniQure N.V. entered into a material definitive agreement. The filing also indicates other events and includes financial statements and exhibits. The company is incorporated in The Netherlands and its principal executive offices are located in Amsterdam.
Why It Matters
This 8-K filing signals a significant new agreement for uniQure N.V., which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Players & Entities
- uniQure N.V. (company) — Registrant
- September 25, 2025 (date) — Date of earliest event reported
- Amsterdam (location) — Principal Executive Offices
- The Netherlands (location) — State or Other Jurisdiction of Incorporation
FAQ
What is the nature of the material definitive agreement entered into by uniQure N.V. on September 25, 2025?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on September 25, 2025.
What other events are reported in this 8-K filing?
The filing indicates 'Other Events' but does not provide specific details within the provided text.
Where are uniQure N.V.'s principal executive offices located?
uniQure N.V.'s principal executive offices are located at Paasheuvelweg 25a, 1105 BP Amsterdam, The Netherlands.
When was uniQure N.V. incorporated?
uniQure N.V. was incorporated in The Netherlands.
What is the SEC file number for uniQure N.V.?
The SEC file number for uniQure N.V. is 001-36294.
Filing Stats: 1,034 words · 4 min read · ~3 pages · Grade level 10.1 · Accepted 2025-09-26 21:24:17
Key Financial Figures
- $47.50 — m Shares"), at a price to the public of $47.50 per ordinary share, and, in lieu of ord
- $0.0001 — ublic offering price per share less the $0.0001 per share exercise price of each Pre-Fu
- $323.75 million — from the Offering will be approximately $323.75 million after deducting underwriting discounts
- $300 Million — d "uniQure Announces Pricing of Upsized $300 Million Public Offering." The full text of the
Filing Documents
- tm2526258d3_8k.htm (8-K) — 34KB
- tm2526258d3_ex1-1.htm (EX-1.1) — 248KB
- tm2526258d3_ex4-1.htm (EX-4.1) — 76KB
- tm2526258d3_ex5-1.htm (EX-5.1) — 39KB
- tm2526258d3_ex5-2.htm (EX-5.2) — 12KB
- tm2526258d3_ex99-1.htm (EX-99.1) — 13KB
- tm2526258d3_ex99-1img001.jpg (GRAPHIC) — 13KB
- tm2526258d3_ex5-2img001.jpg (GRAPHIC) — 9KB
- tm2526258d3_ex5-2img002.jpg (GRAPHIC) — 1KB
- tm2526258d3_ex5-2img003.jpg (GRAPHIC) — 1KB
- 0001104659-25-094011.txt ( ) — 714KB
- qure-20250925.xsd (EX-101.SCH) — 3KB
- qure-20250925_lab.xml (EX-101.LAB) — 33KB
- qure-20250925_pre.xml (EX-101.PRE) — 22KB
- tm2526258d3_8k_htm.xml (XML) — 4KB
01. Entry Into a Material
Item 1.01. Entry Into a Material Definitive Agreement. On September 25 , 2025, uniQure N.V. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Leerink Partners LLC, as representative of the several underwriters named therein (the "Underwriters"), relating to an underwritten public offering (the "Offering") of 5,789,473 of the Company's ordinary shares (the "Firm Shares"), at a price to the public of $47.50 per ordinary share, and, in lieu of ordinary shares to certain investors, pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 526,316 of its ordinary shares (the "Pre-Funded Warrant Shares") at the public offering price per share less the $0.0001 per share exercise price of each Pre-Funded Warrant. Under the terms of the Underwriting Agreement, the Company also granted the Underwriters an option, exercisable for 30 days from the date of the Underwriting Agreement (the "Option"), to purchase up to an additional 947,368 of the Company's ordinary shares (the "Optional Shares" and together with the Firm Shares, the "Shares") at the public offering price less the underwriting discounts and commissions. On September 26, 2025, the Underwriters exercised the Option in full. The Company estimates that the net proceeds from the Offering will be approximately $323.75 million after deducting underwriting discounts and commissions and estimated offering expenses. The Pre-Funded Warrants are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than 4.99% or 9.99% of the number of ordinary shares outstanding immediately after giving effect to such exercise. A holder of Pre-Funded Warrants may increase or decrease this percentage not in excess of 19.99% by providing at least 61 days' prior notice to the Company. The Shares and Pre-Funded Warrants will be issued pursuant to a prospectus supp
01 Other Events
Item 8.01 Other Events On September 25, 2025, the Company issued a press release entitled "uniQure Announces Pricing of Upsized $300 Million Public Offering." The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d)Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated as of September 25, 2025, by and between the Company and Leerink Partners LLC, as representative for the several underwriters named therein. 4.1 Form of Pre-Funded Warrant 5.1 Opinion of Rutgers & Posch N.V. 5.2 Opinion of Morgan, Lewis & Bockius LLP 23.1 Consent of Rutgers & Posch N.V. (included in Exhibit 5.1) 23.2 Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.2) 99.1 Press Release of uniQure N.V. dated September 25, 2025. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. UNIQURE N.V. Date: September 26, 2025 By: /s/ Jeannette Potts JEANNETTE POTTS Chief Legal and Compliance Officer